| 27b8c631-941d-4ad1-8aae-fea180b7d218 | Síndrome da deficiência congênita de iodo do tipo misto | E002 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1683 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 25ac3484-cb76-4983-822d-5efa660f5257 | Transtorno hemorrágico devido a anticoagulantes circulantes | D683 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1594 | 1 | 2021-05-25T19:40:03.594000+00:00 | 2021-05-25T19:40:03.594000+00:00 |
| caa59285-a146-435e-b4f5-3cc296713399 | Outros defeitos especificados da coagulação | D688 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1596 | 1 | 2021-05-25T19:40:03.594000+00:00 | 2021-05-25T19:40:03.594000+00:00 |
| 2cac4f47-6c42-4968-835d-a008174eddab | Defeito de coagulação não especificado | D689 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1597 | 1 | 2021-05-25T19:40:03.594000+00:00 | 2025-11-03T17:53:51.492000+00:00 |
| 09698b8e-0abb-483b-8d95-008edeb82ed5 | Linfohistiocitose hemofagocítica | D761 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1630 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 2a627294-8b57-4918-8fee-76f89e8d7e9f | Imunodeficiência combinada grave [SCID] com números baixos de células T e B | D811 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1645 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| e0e997a5-8823-4584-9c26-555fe072c292 | Imunodeficiência combinada grave [SCID] com números baixos ou normais de células B | D812 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1646 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| d5b4b74d-13a4-4bff-b117-a0267019b441 | Hipogamaglobulinemia transitória da infância | D807 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1641 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 8aee58de-eb67-41b0-865f-75e5628ac1b6 | Outras imunodeficiências com predominância de defeitos de anticorpos | D808 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1642 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 576fab82-4be0-4844-b9ff-d87ea34db50c | Imunodeficiência não especificada com predominância de defeitos de anticorpos | D809 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1643 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 29145915-9d20-4958-9151-9a81f6643dc4 | Deficiência de adenosina-deaminase [ADA] | D813 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1647 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 1f523c3d-e7dc-424a-8e77-7a0d1d358b8e | Síndrome de nezelof | D814 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1648 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| bce299e1-33dd-4d54-a12c-45d4ffc0c422 | Deficiência de purina-nucleosídeo fosforilase [pnp] | D815 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1649 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 039dbb9e-5187-4a6d-874f-715172abac7b | Deficiência major classe I do complexo de histocompatibilidade | D816 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1650 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| fc5a0677-e13d-47d7-9730-b17567e830fa | Deficiência major classe II do complexo de histocompatibilidade | D817 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1651 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| a6f896e6-1c3d-400c-9a55-8773957654e0 | Outras deficiências imunitárias combinadas | D818 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1652 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 47a1f3d4-b7fe-4914-86a2-19de3a99708f | Deficiências imunitárias combinadas não especificadas | D819 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1653 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 448afc88-0f3e-4acb-af79-ec7a01baa7f1 | Imunodeficiência associada com outros defeitos major | D82 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 12719 | 1 | 2021-05-25T19:40:03.700000+00:00 | 2021-05-25T19:40:03.700000+00:00 |
| 1327cf36-886f-4f90-878f-d5d43bc51fd8 | Síndrome de Wiskott-Aldrich | D820 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1654 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 334c6b40-a303-4642-82e6-24cb270d0570 | Síndrome de di George | D821 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1655 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| c16e80a6-149a-4aea-b20b-c8d8229cd664 | Imunodeficiência com encurtamento de membros | D822 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1656 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 9bbfd4d8-5e04-4271-b74c-db2e276121f6 | Síndrome da hiperimunoglobulina E [IGE] | D824 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1658 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 6490053f-31ff-40d7-b18b-93a908fa9ea9 | Imunodeficiências associadas com outros defeitos major especificados | D828 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1659 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 1a99284a-d092-4c39-a742-22f4f7b2612c | Imunodeficiência associada com defeitos major não especificados | D829 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1660 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 218263b0-a987-49b8-a2d1-55e0af2a8eee | Imunodeficiência comum váriavel | D83 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 12720 | 1 | 2021-05-25T19:40:03.690000+00:00 | 2021-05-25T19:40:03.690000+00:00 |
| 9465fcca-5f38-4ff0-ba16-672a82c4b597 | Imunodeficiência comum variável com predominância de anormal. do número e da função das células B | D830 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1661 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| cc26bdfd-445a-4018-a9be-b76e569a8290 | Imunodeficiência comum variável com predominância de transtornos imunorregulatórios de células T | D831 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1662 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| f37e4bc1-116d-4d70-83f7-a86eb4025b1a | Imunodeficiência comum variável com auto-anticorpos às células B ou T | D832 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1663 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| f8d683f4-180e-4673-b880-ebabf3f0151e | Outras imunodeficiências comuns variáveis | D838 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1664 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| b9eea2e0-08da-4fa8-a0ed-dd72aaf83663 | Imunodeficiência comum variável não especificada | D839 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1665 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| b4770124-3481-4582-bd5e-7ca236cd6074 | Outras imunodeficiências | D84 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 12721 | 1 | 2021-05-25T19:40:03.690000+00:00 | 2021-05-25T19:40:03.690000+00:00 |
| 7f296469-134e-4ec9-9099-a3a926bb63d2 | Defeito do antígeno-1 da função de linfócito [LFA-1] | D840 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1666 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| c8ac2af5-cc34-46e0-bbba-c4beecae5f5a | Defeitos no sistema complemento | D841 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1667 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| da2ad438-92d5-40e0-aa98-5298c2b13d8c | Outras imunodeficiências especificadas | D848 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1668 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 7b22fb6c-b5a1-485a-bc87-bb498272bb32 | Imunodeficiência não especificada | D849 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1669 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 14a611d9-4cb3-4225-9336-126d129c178b | Sarcoidose | D86 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 12722 | 1 | 2021-05-25T19:40:03.690000+00:00 | 2021-05-25T19:40:03.690000+00:00 |
| dcd9cf15-9c2a-40ae-8a67-633a7b7dd7e6 | Sarcoidose do pulmão | D860 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1670 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| d7ae12f5-4d6e-4c8e-96c8-5839a15e30ce | Sarcoidose dos gânglios linfáticos | D861 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1671 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 662f6faf-8f57-4816-9c68-459731e694d1 | Sarcoidose do pulmão com sarcoidose dos gânglios linfáticos | D862 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1672 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 7338ccb1-b284-4458-a73c-44aca1535a50 | Sarcoidose da pele | D863 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1673 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| dafc2df3-1ff2-4864-90b7-6b54aab230cb | Sarcoidose de outros locais especificados e locais combinados | D868 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1674 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 5f026b21-b4aa-4d26-9a3e-8526df0603fc | Sarcoidose não especificada | D869 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1675 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 475f43f0-48b9-4c1a-9629-c8d70188f5d1 | Outros transtornos que comprometem o mecanismo imunitário não classificados em outra parte | D89 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 12723 | 1 | 2021-05-25T19:40:03.690000+00:00 | 2021-05-25T19:40:03.690000+00:00 |
| b50abe93-1bdc-4ea3-9fc7-e39c7e2a8e93 | Hipergamaglobulinemia policlonal | D890 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1676 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| a23d3c38-5591-4c71-950e-acdc6e1e2e57 | Hipergamaglobulinemia não especificada | D892 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1678 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 67163302-d12f-4b58-86a6-8e8bb0a70124 | Outros transtornos especificados que comprometem o mecanismo imunitário ñ classificados noutra parte | D898 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1679 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 36b8ab2b-b944-400d-a798-f45f44e7d356 | Síndrome de deficiência congênita de iodo | E00 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 12724 | 1 | 2021-05-25T19:40:03.690000+00:00 | 2021-05-25T19:40:03.690000+00:00 |
| 7fb430ff-cbdf-4b17-a9b6-a5959b41f50f | Deficiências imunitárias combinadas | D81 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 12718 | 1 | 2021-05-25T19:40:03.690000+00:00 | 2021-05-25T19:40:03.690000+00:00 |
| 25ea06a8-9839-46fa-a9ac-d048447406b7 | Imunodeficiência combinada grave [SCID] com disgenesia reticular | D810 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1644 | 1 | 2021-05-25T19:40:03.595000+00:00 | 2021-05-25T19:40:03.595000+00:00 |
| 4146b563-f9cd-4752-a669-5cdbeaf3f0a4 | Tireotoxicose factícia | E054 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1707 | 1 | 2021-05-25T19:40:03.596000+00:00 | 2021-05-25T19:40:03.596000+00:00 |